Latest news in the food and nutraceutical industry

6 Jan 2026

Major economic shifts and growing consumer uptake of GLP-1s and AI are shaping how – and what – people eat, according to a Euromonitor market analysis.

31 Dec 2025

US food giant PepsiCo has launched its Simply NKD range, a move it says reimagines its popular products with new formulations free from artificial flavours, dyes, and colours.

29 Dec 2025

Researchers at Wageningen University have developed a metric to assess – and optimise – the protein quality of plant-based meals.

23 Dec 2025

From trade tariffs to heavy metals in protein, we look back at some of the industry’s highlights of 2025 and round up our most-read stories of the year.

19 Dec 2025

Non-profit organisation the Food Foundation has launched a campaign, “Bang in Some Beans”, designed to increase UK consumers’ legume consumption.

16 Dec 2025

Trend forecasters predict that sensory elements will play a larger role, helping food and beverage brands differentiate themselves in a competitive market in 2026.

11 Dec 2025

Whole Foods Market has released its top 2026 trends, predicting that a fibre frenzy will take place next year as health-conscious consumers seek out nutritious, filling options.

9 Dec 2025

With the launch of Novak Djokovic’s sorghum-based brand, the grain’s popularity in the better-for-you snacking sphere is on the rise, thanks to its nutritional and sensory properties.

8 Dec 2025

Plant-based dairy is a maturing market that still faces significant hurdles around taste, functionality, nutrition, and price, but industry is innovating fast, according to experts speaking at Fi Europe.

30 Nov 2025

The Non-UPF Program has extended its certification scheme to the wider food sector, championing a move towards healthier consumption habits.

28 Nov 2025

The Malaysian Palm Oil Council (MPOC) is calling for the European Commission to reconsider its U-turn on the European Union Deforestation Regulation (EUDR).

24 Nov 2025

OXO’s entry into bone broth has turned the spotlight on this small but high-performance category – and there is still scope for growth, especially in the area of GLP-1 support.